long intergenic non-protein coding RNA 2195Genealiases: []
Q-omics provides the consensus-scored LINC02195 profile across patient tissues and cancer cell-line models. LINC02195 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, LINC02195 is differentially expressed in 13, with the highest sampling consensus in KIRC. Additionally, LINC02195 RNA expression shows 12,384 significant protein co-abundance associations, with the highest sampling consensus in BRCA. Together, these results highlight KIRC, and BRCA as cancer lineages where LINC02195 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02195 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02195 survival associations across molecular data types. LINC02195 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02195 RNA expression–survival associations across cancer types. High LINC02195 expression shows unfavorable associations in KIRC, but favorable associations in BLCA, HNSC, SKCM, UCEC and CESC. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for LINC02195 RNA expression.
This table summarizes LINC02195 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 13. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02195. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02195 shows higher tumor expression in KIRC, STAD, BLCA, HNSC, COAD and LUAD. The KIRC box plot shows higher LINC02195 RNA expression in tumor versus normal tissue (log2 FC = +0.874, t-test p < 0.001).
This table shows molecular features associated with LINC02195 in patient tissues and cancer cell lines. In patient samples, LINC02195 shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set.
